杀虫药
抗寄生虫的
恶性疟原虫
罗得西亚布氏锥虫
布氏锥虫
广告
杜氏利什曼原虫
效力
抗寄生虫药
克鲁兹锥虫
化学型
婴儿利什曼原虫
药理学
生物
化学
弓形虫
体外
生物化学
药代动力学
利什曼病
寄生虫寄主
疟疾
内脏利什曼病
色谱法
医学
免疫学
抗体
万维网
病理
计算机科学
基因
精油
作者
Derek A. Leas,Austin G. Sanford,Jianbo Wu,Monica Cal,Marcel Kaiser,Sergio Wittlin,Ryan M. Hemsley,Elyssa B. Darner,LeeAnna M. Lui,Paul H. Davis,Jonathan L. Vennerstrom
标识
DOI:10.1021/acsinfecdis.1c00135
摘要
We now describe the physicochemical profiling, in vitro ADME, and antiparasitic activity of eight N,N′-diarylureas to assess their potential as a broad-spectrum antiprotozoal chemotype. Chromatographic LogD7.4 values ranged from 2.5 to 4.5; kinetic aq. solubilities were ≤6.3 μg/mL, and plasma protein binding ranged from 95 to 99%. All of the compounds had low intrinsic clearance values in human, but not mouse, liver microsomes. Although no N,N′-diarylurea had submicromolar potency against Trypanosoma cruzi, two had submicromolar potencies against Toxoplasma gondii and Trypanosoma brucei rhodesiense, and five had submicromolar potencies against Leishmania donovani. Plasmodium falciparum appeared to be the most susceptible to growth inhibition by this compound series. Most of the N,N′-diarylureas had antiprotozoal selectivities ≥10. One N,N′-diarylurea had demonstrable activity in mouse models of malaria and toxoplasmosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI